Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
|Articles|August 30, 2022
Daily OTC Pearl: On-the-Spot
Author(s)Saro Arakelians, PharmD
Neutrogena On-the-Spot with benzoyl peroxide helps reduce treat acne breakouts.
Advertisement
OTC/Lifestyle Pearl of the Day: On-the-Spot
Indication: Neutrogena On-the-Spot with benzoyl peroxide helps reduce treat acne breakouts.
Insight:
- Active ingredient: Benzoyl peroxide 2.5%.
- Clean the skin thoroughly before applying this product.
- Cover the entire affected area with a thin layer 1 to 3 times daily.
- Because excessive drying of the skin may occur, start with one application daily, then gradually increase to 2 or 3 times daily if needed or directed by a physician.
- If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and consult a physician.
- Keep away from children.
Source:
Advertisement
Related to this article
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.
An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Glucose Monitoring: Timing Makes Every Reading Count
2
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
3
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
4
AHA 2026: Pharmacists at the Center of Cardiometabolic Care
5